High Tide Posts $178M Record Quarter on German Cannabis Expansion

High Tide Inc (HITI) delivered its strongest quarterly performance to date, posting $178.3 million in revenue for Q1 FY2026 ended January 31, representing a 44% year-over-year increase from the prior period. Gross profit reached $44.4 million, marking the company's highest margin quarter as its German medical cannabis operations gained traction following the country's progressive cannabis reforms. The results underscore HITI's successful pivot from purely Canadian retail operations to a diversified North American and European cannabis platform.

The German market expansion proves particularly strategic as Europe's largest economy continues liberalizing its cannabis framework. Germany's medical cannabis market, valued at approximately €500 million annually, offers HITI access to 83 million potential consumers with significantly higher purchasing power than typical North American markets. The company's early entry positions it ahead of major Canadian licensed producers like Canopy Growth and Aurora Cannabis, which have struggled to establish meaningful European footholds despite larger market capitalizations.

HITI's revenue trajectory places it among the top-performing cannabis retailers globally, with quarterly sales now exceeding established operators like Planet 13 Holdings and approaching levels achieved by multi-state operators in mature U.S. markets. The 25% gross margin improvement reflects operational efficiencies gained through supply chain optimization and premium product positioning in European markets where consumers demonstrate less price sensitivity than Canadian recreational buyers.

The quarterly performance arrives as cannabis retail consolidation accelerates across North America, with smaller operators facing margin compression and capital constraints. HITI's international diversification strategy differentiates it from peers concentrated in saturated Canadian markets, where retail oversupply continues pressuring profitability. The company's ability to generate positive operating cash flow while expanding geographically contrasts sharply with cash-burning competitors still dependent on equity financing.

Looking ahead, HITI's German operations provide a foundation for broader European expansion as additional countries consider medical cannabis programs. The company's technology platform and retail expertise translate effectively across jurisdictions, creating scalable revenue opportunities without the regulatory complexity facing cultivation-focused cannabis companies. With German adult-use legalization discussions ongoing, HITI's established infrastructure positions it to capitalize on potential market expansion that could triple addressable consumer demand within two years.